Coronavirus vaccine

London: The United Kingdom said that India’s COVID-19 vaccine Covaxin will be included in its list of approved vaccines for international travellers from November 22. This implies that those vaccinated...

New Delhi: The Central government has placed an order for 1 crore doses of ZyCoV-D COVID-19 vaccine with Ahmedabad-based drug manufacturer Zydus Cadila. ZyCoV-D, which is India’s second indigenous vaccine...

New Delhi: The World Health Organisation (WHO) chief scientist Dr Soumya Swaminathan said that the clearance for using Covaxin on children will take much less time. Her comments came after...

New Delhi: With exactly two months left for 2021 to pass by, where does India’s vaccination coverage stand? According to Union Health minister Mansukh Mandaviya, 78 per cent of the...

New Delhi: Britain had expressed reservations about the vaccination certificate being issued by India, delaying its approval for Covishield vaccine. It led India to resort to a tit-for-tat, and imposing...

A new study has found that a third dose of Pfizer-BioNTech vaccine is more effective in reducing severe COVID-19 symptoms compared to people who have received two doses. The research,...

Rome: Prime Minister Narendra Modi claimed on Saturday that India is ready to produce 5 billion COVID-19 vaccine doses by the end of 2022 which will be available for the...

New Delhi: The wait for Covaxin to be granted emergency use listing status by World Health Organization (WHO) just got prolonged as additional clarifications were sought from Bharat Biotech. But...

United Nations/Geneva: The technical advisory group of the World Health Organisation (WHO) sought “additional clarifications” from Bharat Biotech on Tuesday for its COVID-19 vaccine Covaxin to conduct a final “risk-benefit...

New York: Sensing that India is getting impatient over the delay in approval of its COVID-19 vaccine, the World Health Organization (WHO) said that it cannot cut corners in making...